Sorafenib and haemoglobin decreased 
Sorafenib and haemoglobin decreased Patient Reports February 10, 2012
Sorafenib Side Effects Report #5805953-2
Sorafenib side effect was reported by a Physician from ITALY on July 04, 2008. Male patient, 82 years of age, weighting 176.4 lb, was diagnosed with renal cell carcinoma, gastric ulcer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: gastric ulcer, haemoglobin decreased. Sorafenib dosage: unknown. During the same period patient was treated with OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5899747-X
Sorafenib side effect was reported by a Physician from ITALY on Sept 24, 2008. Male patient, 82 years of age, weighting 176.4 lb, was diagnosed with renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: gastric ulcer, haemoglobin decreased. Sorafenib dosage: unknown. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5595398-5
Sorafenib side effect was reported by a Physician from GERMANY on Jan 16, 2008. Male patient, 56 years of age, weighting 216.1 lb, was diagnosed with renal cell carcinoma, diabetes mellitus, hypertension, gout
, hypothyroidism, thrombosis prophylaxis, dyspnoea and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, gastritis, grand mal convulsion, haemoglobin decreased, malignant neoplasm progression, pleural effusion, reflux oesophagitis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with NOVONORM, BISOPROLOL FUMARATE, ALLOPURINOL, EFEROX, FRAXIPARIN, ALBUTEROL, ATROVENT. Patient was hospitalized. Patient died on 02/18/2006.Sorafenib Side Effects Report #4976150-8
Sorafenib side effect was reported by a Consumer or non-health professional from FRANCE on Apr 03, 2006. Female patient, 44 years of age, weighting 106.7 lb, was diagnosed with renal cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: arthralgia, blood glucose increased, chest pain
, haemoglobin decreased, platelet count increased, pyrexia, renal failure, retinal haemorrhage, retinal vein thrombosis. Sorafenib dosage: unknown. During the same period patient was treated with SOLUPRED, OXYNORM, MOPRAL, CETIRIZINE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5695691-1
Sorafenib side effect was reported by a Physician from UNITED STATES on Mar 27, 2008. Male patient, 76 years of age, was diagnosed with prostate cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, chest pain
, deep vein thrombosis , dysphagia, electrocardiogram abnormal, haematocrit decreased, haemoglobin decreased, muscular weakness. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with MITOXANTRONE, ZOMETA, ULTRAM, BUSPAR, KYTRIL, COMPAZINE, AVODART. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5868402-4
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Aug 26, 2008. Male patient, 81 years of age, weighting 196.2 lb, was diagnosed with prostate cancer
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: atrial fibrillation , atrial flutter, dysuria, haemoglobin decreased, pneumonia , prostate cancer . Sorafenib dosage: TOTAL DAILY DOSE: 200 MG UNIT DOSE: 200 MG. During the same period patient was treated with PREDNISONE, ASPIRIN, TAXOTERE. Patient was hospitalized. Patient died on 06/22/2008.Sorafenib Side Effects Report #5913998-7
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Oct 07, 2008. Male patient, 81 years of age, weighting 196.2 lb, was diagnosed with prostate cancer
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: atrial fibrillation , atrial flutter, dysuria, haemoglobin decreased, pneumonia , prostate cancer . Sorafenib dosage: TOTAL DAILY DOSE: 200 MG UNIT DOSE: 200 MG. During the same period patient was treated with PREDNISONE, ASPIRIN, TAXOTERE. Patient was hospitalized. Patient died on 06/22/2008.Sorafenib Side Effects Report #5857421-X
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Aug 25, 2008. Male patient, weighting 239.6 lb, was diagnosed with prostate cancer
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: atrial fibrillation , chills, haemoglobin decreased, pneumonia , urinary tract infection , white blood cell count increased. Sorafenib dosage: 400 MG PO BID PO. During the same period patient was treated with TAXOTERE, OMAPRAZOLE, MOTOPROLOL, DECADRON SRC, REGLAN, LUPRON, PREDNISONE, BENAZEPRIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5142968-4
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Oct 18, 2006. Female patient, 67 years of age, weighting 160.9 lb, was diagnosed with ovarian cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, hypocalcaemia, hypokalaemia, hypophosphataemia, infection
, palmar-plantar erythrodysaesthesia syndrome, pyrexia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with TOPROL, ASPIRIN, LIPITOR, POTASSIUM CHLORIDE, SENNOKOT, COLACE, TRIAMCINOLONE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5169658-6
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Oct 18, 2006. Female patient, 67 years of age, weighting 160.9 lb, was diagnosed with ovarian cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bacteria urine identified, blood urine present, culture urine positive, haematocrit decreased, haemoglobin decreased, hypersensitivity, hypocalcaemia, hypokalaemia, hypophosphataemia. Sorafenib dosage: UNIT DOSE: 200 MG. During the same period patient was treated with TOPROL, ASPIRIN, LIPITOR, POTASSIUM CHLORIDE, SENNOKOT, COLACE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5034702-3
Sorafenib side effect was reported by a Physician from UNITED STATES on June 02, 2006. Male patient, 53 years of age, weighting 158.3 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: aortic valve incompetence, bronchiolitis, cardiac failure, dyspnoea, haemoglobin decreased, haemothorax, lung infiltration, palmar-plantar erythrodysaesthesia syndrome, pericardial effusion. Sorafenib dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, FLOMAX, LEXAPRO, OXYCODONE, PREDNISONE, TEMAZEPAM, PROTONIX. Patient was hospitalized. Patient died on 06/05/2006.
Sorafenib Side Effects Report #5685481-8
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Mar 19, 2008. Male patient, 64 years of age, was diagnosed with metastatic squamous cell carcinoma, pain
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: coma, haemoglobin decreased, haemorrhage intracranial, pneumonia aspiration, prothrombin time prolonged. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DURAGESIC. Patient was hospitalized. Patient died on 03/14/2008.Sorafenib Side Effects Report #5324959-3
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 07, 2007. Female patient, 78 years of age, weighting 121.3 lb, was diagnosed with metastatic renal cell carcinoma, pulmonary embolism
, gastrooesophageal reflux disease, hypertension, hypothyroidism, nausea , pain and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood chloride decreased, coagulopathy, fall , gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, haemorrhoids, hip fracture, hypotension. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COUMADIN, PROTONIX, DIOVAN, LEVOTHYROXINE, COMPAZINE, VICODIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4888258-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 10, 2006. Male patient, 78 years of age, weighting 146.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, atrial fibrillation , constipation , creatine phosphokinase decreased, dry skin, haemoglobin decreased, lung neoplasm, malignant neoplasm progression, nausea . Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with MS CONTIN, VICODIN. Patient was hospitalized. Patient died on 01/08/2006.Sorafenib Side Effects Report #4996191-4
Sorafenib side effect was reported by a Health Professional from FRANCE on Apr 19, 2006. Male patient, 74 years of age, weighting 163.1 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, fall
, haemoglobin decreased, renal failure acute. Sorafenib dosage: 800 MG, TOTAL DAILY, ORAL. During the same period patient was treated with BIPRETERAX, FLODIL, SYMBICORT, PANTOPRAZOLE, EFFERALGAN, PRIMALAN, STILNOX, DIPROSALIC. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5207013-0
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 03, 2007. Male patient, 69 years of age, weighting 176.4 lb, was diagnosed with metastatic renal cell carcinoma, oedema, gastrooesophageal reflux disease, hypothyroidism, fatigue, pain
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: fatigue, gastrointestinal haemorrhage, haemoglobin decreased, hypocalcaemia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with LASIX, OMEPRAZOLE, SYNTHROID, TESTOSTERONE, ROXANOL, MS CONTIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5122663-8
Sorafenib side effect was reported by a Physician from UNITED STATES on Nov 17, 2005. Male patient, 69 years of age, weighting 176.4 lb, was diagnosed with metastatic renal cell carcinoma, oedema, gastrooesophageal reflux disease, hypothyroidism, fatigue, pain
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abasia, depression , dizziness , fatigue, gastrointestinal haemorrhage, haemoglobin decreased, hypocalcaemia, hypotension, hypovolaemia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with LASIX, OMEPRAZOLE, SYNTHROID, TESTOSTERONE, ROXANOL, MS CONTIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5106375-2
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2006. Male patient, 68 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alopecia, asthenia, dehydration, dysphagia, gastric haemorrhage, haematochezia, haemoglobin decreased, intestinal perforation. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with SYNTHROID, ZYRTEC, ZOLOFT, PRILOSEC, BENADRYL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4907046-5
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 26, 2006. Male patient, 68 years of age, weighting 219.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood sodium decreased, diarrhoea, haematocrit decreased, haemoglobin decreased, rectal abscess. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with ATENOLO, PROTONIX, SYNTHROID. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4927901-X
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 14, 2006. Male patient, 68 years of age, weighting 219.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood sodium decreased, diarrhoea, haematocrit decreased, haemoglobin decreased, rectal abscess. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with ATENOLOL, PROTONIX, SYNTHROID. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4932101-3
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 20, 2006. Male patient, 68 years of age, weighting 219.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood sodium decreased, diarrhoea, haematocrit decreased, haemoglobin decreased, nausea
, rectal abscess. Sorafenib dosage: 400 MG, BID; ORAL. During the same period patient was treated with ATENOLOL, PROTONIX, SYNTHROID. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4977059-6
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2006. Male patient, 68 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alopecia, asthenia, dehydration, dysphagia, faeces discoloured, gastric haemorrhage, haematochezia, haemoglobin decreased. Sorafenib dosage: ORAL; 400 MG, BID, ORAL. During the same period patient was treated with SYNTHROID, ZYRTEC, ZOLOFT, PRILOSEC, BENADRYL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4910411-3
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 31, 2006. Male patient, 66 years of age, weighting 132.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood pressure diastolic decreased, haemoglobin decreased, pharyngitis, polychromasia, red blood cell count decreased, red blood cell schistocytes present, red cell distribution width increased, reticulocyte percentage increased. Sorafenib dosage: unknown. During the same period patient was treated with ZESTRIL, ZOCOR, ASPIRIN, PERCOCET, ZOFRAN. Patient recovered.
Sorafenib Side Effects Report #5019374-6
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 15, 2006. Male patient, 65 years of age, weighting 148.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: diarrhoea, haematocrit decreased, haemoglobin decreased, hypotrichosis, mitral valve incompetence, pain of skin, palmar-plantar erythrodysaesthesia syndrome, postnasal drip, pulmonary embolism
. Sorafenib dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.Sorafenib Side Effects Report #5112510-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 13, 2006. Male patient, 62 years of age, was diagnosed with metastatic renal cell carcinoma, pain
, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: balance disorder, blood albumin decreased, blood glucose increased, cognitive disorder, convulsion, haematocrit decreased, haemoglobin decreased, hemiparesis, hypoaesthesia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DURAGESIC, PROTONIX, GLIPIZIDE, GLUCOPHAGE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5163251-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 13, 2006. Male patient, 62 years of age, was diagnosed with metastatic renal cell carcinoma, pain
, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood glucose increased, convulsion, haematocrit decreased, haemoglobin decreased, hemiparesis, hypoaesthesia, lymphocyte count decreased, neutrophil percentage increased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DURAGESIC, PROTONIX, GLIPIZIDE, GLUCOPHAGE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5023998-X
Sorafenib side effect was reported by a Physician from UNITED STATES on May 25, 2006. Male patient, 60 years of age, weighting 141.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, blood alkaline phosphatase increased, blood calcium increased, flank pain, haemoglobin decreased, lethargy, pleural effusion, white blood cell count increased. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with PRANDIN, GLIPIZIDE, MEGESTROL, RESTORIL, ARANESP, NORVASC, TENORMIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5161001-1
Sorafenib side effect was reported by a Physician from POLAND on Oct 12, 2006. Female patient, 57 years of age, weighting 114.6 lb, was diagnosed with metastatic renal cell carcinoma, haemoglobin decreased, urinary tract infection
, blood calcium decreased and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiovascular insufficiency, gastrointestinal haemorrhage, haemoglobin decreased, mechanical ileus, shock. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with INTERFERON, WHOLE BLOOD, WHOLE BLOOD, CIPROFLOXACIN, BLOOD SERUM, CALCIUM. Patient was hospitalized. Patient died on 10/06/2006.Sorafenib Side Effects Report #5192672-1
Sorafenib side effect was reported by a Physician from POLAND on Oct 12, 2006. Female patient, 57 years of age, weighting 114.6 lb, was diagnosed with metastatic renal cell carcinoma, haemoglobin decreased, urinary tract infection
, blood calcium decreased and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiovascular insufficiency, gastrointestinal haemorrhage, haemoglobin decreased, mechanical ileus. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with INTERFERON, WHOLE BLOOD, WHOLE BLOOD, CIPROFLOXACIN, BLOOD SERUM, CALCIUM. Patient was hospitalized. Patient died on 10/06/2006.Sorafenib Side Effects Report #4888257-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 05, 2006. Female patient, 55 years of age, weighting 124.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood potassium decreased, cardiomegaly, chest x-ray abnormal, dehydration, diarrhoea, haemoglobin decreased, interstitial lung disease, oedema, renal failure. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with LUNESTA, PERCOCET, IMODIUM, COMPAZINE, ATIVAN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5122841-8
Sorafenib side effect was reported by a Physician from UNITED STATES on May 10, 2006. Male patient, 54 years of age, weighting 143.3 lb, was diagnosed with metastatic renal cell carcinoma, hypertension, pain
, metastases to bone, peptic ulcer , back pain , anaemia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bone lesion, dizziness , duodenal ulcer, gastrointestinal haemorrhage, haemoglobin decreased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with LISINOPRIL, NORVASC, HYDROCHLOROTHIAZIDE, OXYCODONE, ZOMETA, NEXIUM, BACLOFEN, FERROUS GLUCONATE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5110136-8
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 08, 2006. Male patient, 53 years of age, weighting 152.1 lb, was diagnosed with metastatic renal cell carcinoma, arthritis
, anxiety , convulsion, pain and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, haemoglobin decreased, pain , retching, weight decreased. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CELEBREX, DOXEPIN, NEURONTIN, MS CONTIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5128496-0
Sorafenib side effect was reported by a Physician from UNITED STATES on May 10, 2006. Male patient, 53 years of age, weighting 143.3 lb, was diagnosed with metastatic renal cell carcinoma, hypertension, pain
, metastases to bone, peptic ulcer , back pain , anaemia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bone lesion, duodenal ulcer, duodenal ulcer haemorrhage, haematemesis, haemoglobin decreased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with LISINOPRIL, NORVASC, HYDROCHLOROTHIAZIDE, OXYCODONE, ZOMETA, NEXIUM, BACLOFEN, FERROUS GLUCONATE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4919360-8
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 02, 2006. Male patient, 50 years of age, weighting 148.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: gastritis erosive, gastrointestinal ulcer, haematocrit decreased, haemoglobin decreased, haemorrhoids, hypotension, mean cell volume abnormal, red blood cell count decreased, stress ulcer. Sorafenib dosage: unknown. During the same period patient was treated with LANOXIN, LOTENSIN HCT, PROCHLORPERAZINE, OXYCODONE, WELLBUTRIN, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4927906-9
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2006. Male patient, 50 years of age, weighting 148.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: gastric ulcer, gastritis erosive, haematochezia, haematocrit decreased, haemoglobin decreased, haemorrhage, haemorrhoids, hypotension, mean cell volume decreased. Sorafenib dosage: 200 MG BID ORAL; 400 MG BID ORAL. During the same period patient was treated with LANOXIN, LOTENSIN HCT, PROCLORPERAZINE, OXYCODONE, WELLBUTRIN, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5108825-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 04, 2006. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood calcium decreased, disease progression, haemoglobin decreased, headache
, hyponatraemia, musculoskeletal pain, paraesthesia, wound dehiscence. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with FENTANYL, OXYCODONE, CELEXA, PEPCID, DIAZEPAM, TYLENOL, LYRICA, SENOKOT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5158391-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 04, 2006. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: back pain
, blood bilirubin increased, blood calcium decreased, disease progression, haemoglobin decreased, headache , hypocalcaemia, hyponatraemia, infection . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with FENTANYL, OXYCODONE, CELEXA, PEPCID, DIAZEPAM, TYLENOL, LYRICA, SENOKOT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5165365-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 04, 2006. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: back pain
, blood bilirubin increased, blood urea decreased, disease progression, haemoglobin decreased, headache , hypocalcaemia, hyponatraemia, infection . Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with FENTANYL, OXYCODONE, CELEXA, PEPCID, DIAZEPAM, TYLENOL, LYRICA, SENOKOT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4888254-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 04, 2006. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: back pain
, blood bilirubin increased, blood sodium decreased, blood urea decreased, disease progression, haemoglobin decreased, wound dehiscence. Sorafenib dosage: 400 MG, BID; ORAL. During the same period patient was treated with FENTANYL, OXYCODONE, CELEXA, PEPCID, DIAZEPAM, TYLENOL, LYRICA, SENOKOT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4961103-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Mar 17, 2006. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: back pain
, blood bilirubin increased, blood sodium decreased, cancer pain, haemoglobin decreased, headache , malignant neoplasm progression, wound dehiscence, wound secretion. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with FENTANYL, OXYCODONE, CELEXA, PEPCID, DIAZEPAM, TYLENOL, LYRICA, SENOKOT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5000044-5
Sorafenib side effect was reported by a Consumer or non-health professional from FRANCE on Apr 27, 2006. Female patient, 44 years of age, weighting 106.7 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood glucose increased, cerebral venous thrombosis, haemoglobin decreased, platelet count increased, protein total increased, renal failure, retinal haemorrhage, retinal vein thrombosis. Sorafenib dosage: unknown. During the same period patient was treated with SOLUPRED, OXYNORM, MOPRAL, CETIRIZINE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5023996-6
Sorafenib side effect was reported by a Physician from UNITED STATES on May 31, 2006. Female patient, 46 years of age, weighting 156.7 lb, was diagnosed with metastatic neoplasm, metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood sodium decreased, cerebral haemorrhage, decreased appetite, epistaxis, eye pain, haemoglobin decreased, hepatorenal syndrome, hypersplenism, hypertension. Sorafenib dosage: 400 MG, BID, ORAL; SEE IMAGE. During the same period patient was treated with DACARBAZINE, EFFEXOR, AVALIDE, COMPAZINE, VICODIN ES, DILAUDID, AQUABID DM. Patient was hospitalized. Patient died on 03/03/2006.
Sorafenib Side Effects Report #5158387-0
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 21, 2006. Male patient, 59 years of age, weighting 224.9 lb, was diagnosed with metastatic malignant melanoma, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, candidiasis, chills, dehydration, diarrhoea, haematocrit decreased, haemoglobin decreased, hypotension, nausea
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5115665-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Apr 18, 2006. Male patient, 55 years of age, weighting 163.1 lb, was diagnosed with metastatic malignant melanoma, gastrooesophageal reflux disease, rash
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, febrile neutropenia, haematocrit decreased, haemoglobin decreased, lymphocyte percentage increased, osteopenia, platelet count decreased, red blood cell count decreased. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, PEPCID OTC, BENADRYL, DECADRON. Patient was hospitalized. Patient died on 06/10/2006.Sorafenib Side Effects Report #5049931-2
Sorafenib side effect was reported by a Physician from UNITED STATES on June 30, 2006. Male patient, 54 years of age, weighting 164.0 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, cough, febrile neutropenia, haematocrit decreased, haemoglobin decreased, lymphocyte percentage increased, myalgia, osteopenia, platelet count decreased. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, PEPCID, BENADRYL, DECADRON. Patient was hospitalized. Patient died on 06/08/2006.
Sorafenib Side Effects Report #4990589-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Apr 18, 2006. Female patient, 54 years of age, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: body temperature increased, device failure, escherichia infection, haemoglobin decreased, impaired healing, postoperative wound infection. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with TEMOZOLOMIDE, ANTIBIOTICS, LOVENOX, COUMADIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5036853-6
Sorafenib side effect was reported by a Physician from UNITED STATES on June 16, 2006. Female patient, 54 years of age, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiac disorder, escherichia infection, haemoglobin decreased, impaired healing, wound infection bacterial. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with TEMOZOLOMIDE, ANTIBIOTICS, LOVENOX, COUMADIN. Patient was hospitalized. Patient died on 05/20/2006.
Sorafenib Side Effects Report #4557147-9
Sorafenib side effect was reported by a Health Professional from on Jan 04, 2005. Male patient, 52 years of age, weighting 173.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, chromaturia, dehydration, haemoglobin decreased, jaundice
, liver function test abnormal, pancreatic haemorrhage, pancreatitis, stent occlusion. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with DACARBAZINE, CHLORIDE, AUGMENTIN, PEPPERMINT WATER, NYSTATIN, CHLORHEXIDINE, MILPAR, TYLENOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4586781-5
Sorafenib side effect was reported by a Health Professional from on Feb 07, 2005. Male patient, 52 years of age, weighting 173.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: gamma-glutamyltransferase increased, haemoglobin decreased, pancreatic haemorrhage, pancreatitis, stent occlusion, surgical procedure repeated. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with DACARBAZINE, CHLORIDE, AUGMENTIN, PEPPERMINT WATER, MYSTATIN, CHLORHEXIDINE, MILPAR, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4608222-1
Sorafenib side effect was reported by a Health Professional from on Mar 02, 2005. Male patient, 52 years of age, weighting 173.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: gamma-glutamyltransferase increased, haemoglobin decreased, influenza like illness, liver function test abnormal, malaise, metastases to pancreas, pancreatic haemorrhage, pancreatitis, stent occlusion. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with DACARBAZINE, CHLORIDE, AUGMENTIN, PEPPERMINT WATER, NYSTATIN, CHLORHEXIDINE, MILPAR, PARACETAMOL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4634832-1
Sorafenib side effect was reported by a Health Professional from on Apr 05, 2005. Male patient, 52 years of age, weighting 173.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, dehydration, gamma-glutamyltransferase increased, haemoglobin decreased, infection
, influenza like illness, malaise, metastases to pancreas, pancreatic haemorrhage. Sorafenib dosage: 200 MG, BID; ORAL. During the same period patient was treated with DACARBAZINE, CHLORIDE, AUGMENTIN, PEPPERMINT WATER, NYSTATIN, CHLORHEXIDINE, MILPAR, PARACETAMOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4653392-2
Sorafenib side effect was reported by a Health Professional from on Apr 25, 2005. Male patient, 52 years of age, weighting 173.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bacterial infection
, cough, dehydration, haemoglobin decreased, influenza like illness, pancreatic carcinoma metastatic, pancreatic haemorrhage, pancreatitis, stent occlusion. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with DACARBAZINE, CHLORIDE, AUGMENTIN, PEPPERMINT WATER, NYSTATIN, CHLORHEXIDINE, MILPAR, PARACETAMOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4634832-1
Sorafenib side effect was reported by a Health Professional from UNITED KINGDOM on Apr 05, 2005. Male patient, 52 years of age, weighting 173.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, dehydration, gamma-glutamyltransferase increased, haemoglobin decreased, infection
, influenza like illness, malaise, metastases to pancreas, pancreatic haemorrhage. Sorafenib dosage: 200 MG, BID; ORAL. During the same period patient was treated with DACARBAZINE, CHLORIDE, AUGMENTIN, PEPPERMINT WATER, NYSTATIN, CHLORHEXIDINE, MILPAR, PARACETAMOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4653392-2
Sorafenib side effect was reported by a Health Professional from UNITED KINGDOM on Apr 25, 2005. Male patient, 52 years of age, weighting 173.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bacterial infection
, cough, dehydration, haemoglobin decreased, influenza like illness, pancreatic carcinoma metastatic, pancreatic haemorrhage, pancreatitis, stent occlusion. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with DACARBAZINE, CHLORIDE, AUGMENTIN, PEPPERMINT WATER, NYSTATIN, CHLORHEXIDINE, MILPAR, PARACETAMOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5811993-X
Sorafenib side effect was reported by a Physician from GERMANY on July 10, 2008. Male patient, 85 years of age, weighting 176.4 lb, was diagnosed with malignant melanoma, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Sorafenib dosage: AS USED: 400 MG. During the same period patient was treated with MOBLOC. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5841278-7
Sorafenib side effect was reported by a Physician from GERMANY on Aug 06, 2008. Male patient, 85 years of age, weighting 176.4 lb, was diagnosed with malignant melanoma, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with MOBLOC, ADALAT, PARACETAMOL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5856106-3
Sorafenib side effect was reported by a Physician from GERMANY on Aug 19, 2008. Male patient, 85 years of age, weighting 176.4 lb, was diagnosed with malignant melanoma, hypertension, pyrexia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with MOBLOC, ADALAT, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4962202-5
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 16, 2006. Male patient, 59 years of age, weighting 224.0 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, candidiasis, chills, dehydration, diarrhoea, haematocrit decreased, haemoglobin decreased, hypotension, malignant melanoma. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN, GLYBURIDE, METHADONE, GABAPENTIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4973878-0
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 30, 2006. Male patient, 59 years of age, weighting 224.0 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: body temperature increased, candidiasis, diarrhoea, haematocrit decreased, haemoglobin decreased, neutropenia, orthostatic hypotension, platelet count decreased, white blood cell count decreased. Sorafenib dosage: 400 MG BID ORAL. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN, GLYBURIDE, METHADONE, GABAPENTIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5004567-4
Sorafenib side effect was reported by a Health Professional from UNITED STATES on May 04, 2006. Male patient, 59 years of age, weighting 224.0 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: candidiasis, dehydration, diarrhoea, haematocrit decreased, haemoglobin decreased, hypotension, neutropenia, platelet count decreased, pyrexia. Sorafenib dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN, GLYBURIDE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5008719-9
Sorafenib side effect was reported by a Physician from UNITED STATES on May 10, 2006. Male patient, 59 years of age, weighting 224.0 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, blood creatinine increased, candidiasis, chills, dehydration, diarrhoea, haematocrit decreased, haemoglobin decreased, nausea
. Sorafenib dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN, GLYBURIDE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4882433-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 01, 2006. Female patient was diagnosed with acute myeloid leukaemia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, hypokalaemia. Sorafenib dosage: 400 MG, BID, ORAL. Patient recovered.
Sorafenib Side Effects Report #4919770-9
Sorafenib side effect was reported by a Consumer or non-health professional from GERMANY on Feb 08, 2006. Male patient, 55 years of age, weighting 207.2 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, disease progression, dyspnoea, gastritis, gastrooesophageal reflux disease, grand mal convulsion, haemoglobin decreased, metastases to abdominal cavity. Sorafenib dosage: unknown. During the same period patient was treated with NOVONORM, RISOPROLOL, ALLOPURINOL, EFEROX, FRAXIPARIN, SALBUTAMOL, ATROVENT. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4928397-4
Sorafenib side effect was reported by a Consumer or non-health professional from GERMANY on Feb 17, 2006. Male patient, 55 years of age, weighting 207.2 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, gastritis, grand mal convulsion, haemoglobin decreased, hypoalbuminaemia, pleural effusion, pneumonia
, reflux oesophagitis. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with NOVONORM, BISOPROLOL, ALLOPURINOL, EFEROX, FRAXIPARIN, SALBUTAMOL, ATROVENT. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5048472-6
Sorafenib side effect was reported by a Health Professional from UKRAINE on June 26, 2006. Male patient, 50 years of age, weighting 194.0 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: acute myocardial infarction, arteriosclerosis, blood pressure increased, cardiac failure chronic, dry skin, haemoglobin decreased, red blood cell sedimentation rate increased, tachycardia. Sorafenib dosage: 400 MG, BID, ORAL. Patient was hospitalized. Patient recovered.